Anemia, a condition characterized by a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood, presents a complex diagnostic challenge for healthcare professionals due to its multifactorial etiology. This article aims to provide a comprehensive guide to the diagnostic approach to anemia.
Anemia can be classified based on the size of RBCs (microcytic, normocytic, or macrocytic), or based on the etiology (nutritional, hemolytic, aplastic, or anemia of chronic disease). This initial classification can guide further diagnostic testing.
The first step in diagnosing anemia is a complete blood count (CBC) to assess RBC count, hemoglobin levels, and mean corpuscular volume (MCV). If anemia is confirmed, reticulocyte count, peripheral smear, and other specific tests such as iron studies or vitamin B12 levels can help determine the cause.
Nutritional anemias, such as iron deficiency anemia and vitamin B12 deficiency anemia, can be confirmed with serum ferritin and serum B12 measurements, respectively. A trial of supplementation can also be diagnostic.
Hemolytic anemia can be suspected from a high reticulocyte count and confirmed with tests like direct Coombs test. Aplastic anemia, a bone marrow failure syndrome, requires bone marrow biopsy for confirmation.
Anemia of chronic disease, now also called anemia of inflammation, can be diagnosed when anemia occurs in the setting of chronic illnesses like autoimmune diseases, infections, or malignancies, and other causes have been ruled out.
Understanding the complexity of anemia and its various types is crucial for healthcare professionals. A systematic approach to diagnosis, based on initial classification and targeted testing, can help identify the underlying cause and guide appropriate treatment.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation